Skip to main content

Isabel Campos Varela

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Isabel Campos Varela

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Research lines

Transplantament hepàtic

Sarcopènia i fragilitat

Malaltia metabòlica i NASH pre-transplantament

Nutrició en el trasplantament


Serveis o tecnologies rellevants:


Bioimpedància

IP: Isabel Campos Varela

Projects

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Victor Manuel Vargas Blasco, Maria Buti Ferret, Montserrat Gomez Perez, Torrens Buscató, Maria Margarita, Judit Vico Romero, Josep Quer Sivila, Adriana Palom Agusti, Juan Manuel Pericàs Pulido, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Daniel Martinez Vazquez, Laura Puente Ramo, Isabel Campos Varela, María Bermúdez Ramos, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Elena de Sena Fernández, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, Jesus Manuel Rivera Esteban, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano, Cesar Jimenez Hernandez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

Functional Monitoring of Virus-specific T and B cell Immune Responses in Solid Organ Transplant Recipients receiving SARS-CoV-2 Vaccination (MoniToR)

IP: Oriol Bestard Matamoros
Collaborators: Isabel Campos Varela, Mariona Juvé Torres, Manuel López Meseguer
Funding agency: Fundació La Marató de TV3
Funding: 172450
Reference: 202101-30
Duration: 20/10/2021 - 20/10/2023

Evaluación de la sarcopenia en pacientes con cirrosis hepática mediante bioimpedancia y ecografía de muslo

IP: Isabel Campos Varela
Collaborators: Lluis Castells Fusté, Nuria Roson Gradaille, Ernest Hidalgo Llompart
Funding agency: Instituto de Salud Carlos III
Funding: 84095
Reference: PI19/00330
Duration: 01/01/2020 - 30/06/2024

Expansión/restauración funcional de células CD4 NS3 específicas autólogas en la prevención de la recurrencia VHC post-trasplante hepático: optimización del proceso para uso clínico

IP: Juan Ignacio Esteban Mur
Collaborators: Itxarone Izaskun Bilbao Aguirre, Lluis Castells Fusté, Silvia Sauleda Oliveras, Isabel Campos Varela, Marta Bes Maijo, Maria Madeleine Piron
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI10/01505
Duration: 01/01/2011 - 30/06/2014

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Estrella Caballero Requero

Estrella Caballero Requero

Microbiology
Read more
Brigidi , Serena

Brigidi , Serena

Main researcher
Maternal and Fetal Medicine
Read more
Martincic , Markus

Martincic , Markus

Tècnic/a Grau Superior
International Projects Unit
Competitive Projects Area
Read more
Lluis Armadans Gil

Lluis Armadans Gil

Main researcher
Epidemiology and Public Health
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.